PROK

Conviction 24HealthcareScan · Thu, Jun 25, 2026

PROK$1.70-3.95%

ResistanceSupportVol 14

Vol MA14 825.26K

Mar 26Apr 14May 1May 19Jun 8Jun 25

PROKIDNEY CORP.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.prokidney.com ↗

Price1.70

Change-3.95%

Gap-0.56%

Rel volume2.21×

Avg volume948.12K

Avg $ vol1.68M

SMA 201.76

SMA 501.82

SMA 2002.23

Price vs 50-6.46%

Price vs 200-23.86%

MA stackbearish

50/200 cross—

Supertrenddown · 1.93

RSI (14)45

MACD hist0.01

MACD crossbull · 5d

Stoch %K / %D29 / 47

ADX (14)12

+DI / −DI16 / 18

RSI divergence—

MACD divergence—

ATR %+7.41%

ADR %6.85%

52w high5.18

52w low0.5652

From 52w high-67.18%

Above 52w low+200.78%

New 52w highNo

SqueezeOn · 7d

Bollinger width17.30%

%B0.31

Donchian pos25.71%

Donchian high1.96

Donchian low1.61

AVWAP (52w high)3.75

vs AVWAP high-54.65%

AVWAP (52w low)3.56

vs AVWAP low-52.31%

OBV trendFlat

Chaikin MF (20)-0.03

Today vs 20d2.21×

Avg vol (14d)825.26K

Avg vol (20d)948.12K

Avg $ vol (20d)1.68M

Market cap104.62M

RS 3m (vs SPY)-13.37%

RS 6m (vs SPY)-33.05%

RS line new highNo

Trend template1/8

Technical rank17.2

1 week-2.86%

1 month+0.59%

3 months-7.10%

6 months-30.89%

1 year+163.48%

YTD-23.77%

P/E-1.52

P/B-0.10

P/S117.15

P/FCF-0.77

EPS-0.2300

Div yield—

ROE6.74%

ROA-23.56%

Debt/Eq—

Current9.06

EV/EBITDA-0.02

Gross margin—

Net margin—

Rev growth1075.00%

EPS growth-12.75%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value2.72M

Revenue226K

Net income-20.04M

Gross profit—

Free cash flow-135.31M

IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

ExchangeNasdaq

Shares out205.2M

Employees231

ListedTue, Jul 12, 2022

Free float102.88M

Float %72.7%

Short interest18.03M

Days to cover18.4d

Short volume80.1%

Squeeze score95 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction24 / 100

Pattern quality—

Tech rank17.2 / 100

Group rank50 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance1.99

Support1.57

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in PROK

All disclosures →

No recent disclosed trades by Congress in PROK. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in PROK · 7 buys

Insider	Side	Shares	Value	Traded	Filed
Legorreta Pablo G. Director · Director stock option (right to buy) · 2026-05-28	Grant	135K	$0	2026-05-28	2026-05-29
Jimenez Santos Jose Ignacio Director · Director stock option (right to buy) · 2026-05-28	Grant	135K	$0	2026-05-28	2026-05-29
Sinha Uma Director · Director stock option (right to buy) · 2026-05-28	Grant	135K	$0	2026-05-28	2026-05-29
Lotvin Alan Director · Director stock option (right to buy) · 2026-05-28	Grant	135K	$0	2026-05-28	2026-05-29
Fox Jennifer A. Director · Director stock option (right to buy) · 2026-05-28	Grant	135K	$0	2026-05-28	2026-05-29
DOYLE WILLIAM F Director · Director stock option (right to buy) · 2026-05-28	Grant	135K	$0	2026-05-28	2026-05-29
Pereira Brian JG Director · Director stock option (right to buy) · 2026-05-28	Grant	135K	$0	2026-05-28	2026-05-29

SEC filings

EDGAR filings in PROK

EDGAR →

No recent SEC filings on file for PROK.

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.